Antiviral Therapy · 2005 · 171 citations · 30 references
Life SciencesImmunologyInfectious DiseasesCellular ImmunologyInnate ImmunityMolecular ImmunologyAntiviral ImmunityCell-mediated ImmunityHuman Leukocyte Antigen SystemNatural Killer Cell BiologyNatural Killer Cell FunctionNatural Killer Cell RegulationCell LysisCytotoxic T Lymphocyte EpitopesHla Antigen ExpressionHla Class I MoleculesHost Immune ControlHost Immune ModulationImmune Cell CytotoxicityMhc Class I Molecules
HIV has evolved several strategies to evade recognition by the host immune system including down-regulation of major histocompatibility complex (MHC) class I molecules. However, reduced expression of MHC class I molecules may stimulate natural killer (NK) cell lysis in cells of haematopoietic lineage. Here, we describe how HIV counteracts stimulation of NK cells by stabilizing surface expression of the non-classical MHC class I molecule, HLA-E. We demonstrate enhanced expression of HLA-E on lymphocytes from HIV-infected patients and show that in vitro infection of lymphocytes with HIV results in up-regulation of HLA-E expression and reduced susceptibility to NK cell cytotoxicity. Using HLA-E transfected K-562 cells, we identified the well-known HIV T-cell epitope p24 aa14-22a as a ligand for HLA-E that stabilizes surface expression of HLA-E, favouring inhibition of NK cell cytotoxicity. These results propose HIV-mediated up-regulation of HLA-E expression as an additional evasion strategy targeting the antiviral activities of NK cells, which may contribute to the capability of the virus in establishing chronic infection.
30
Francisco Borrego, Matthias Ulbrecht, Elisabeth H. Weiss et al. · The Journal of Experimental Medicine · 1998 · 715 citations · Full text
Marylyn M. Addo, Xu G. Yu, Almas Rathod et al. · Journal of Virology · 2003 · 662 citations · Full text